Hagit Binder
Operationeel Directeur bij NEUROSENSE THERAPEUTICS LTD.
Vermogen: 23 760 $ op 31-05-2024
Profiel
Hagit Binder is currently the Chief Operating Officer at Neurosense Therapeutics Ltd.
Prior to this, she worked as the VP-Projects & Marketing at Nextar Chempharma Solutions Ltd.
from 2018 to 2022.
Ms. Binder completed her undergraduate, graduate, and MBA degrees at Bar-Ilan University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-04-2024 | 22 000 ( 0.13% ) | 23 760 $ | 31-05-2024 |
Actieve functies van Hagit Binder
Bedrijven | Functie | Begin |
---|---|---|
NEUROSENSE THERAPEUTICS LTD. | Operationeel Directeur | - |
Eerdere bekende functies van Hagit Binder
Bedrijven | Functie | Einde |
---|---|---|
Nextar Chempharma Solutions Ltd.
Nextar Chempharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Nextar Chempharma Solutions Ltd. is an Israeli biotechnology company that specializes in brain and central nervous system treatments. The private company is based in Ness Ziona, Israel. In addition to this, Nextar also serves as a contract development and manufacturing organization (CDMO) and has been involved in the development of over 120 innovative products. | Verkoop & Marketing | 01-01-2022 |
Opleiding van Hagit Binder
Bar-Ilan University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NEUROSENSE THERAPEUTICS LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Nextar Chempharma Solutions Ltd.
Nextar Chempharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Nextar Chempharma Solutions Ltd. is an Israeli biotechnology company that specializes in brain and central nervous system treatments. The private company is based in Ness Ziona, Israel. In addition to this, Nextar also serves as a contract development and manufacturing organization (CDMO) and has been involved in the development of over 120 innovative products. | Health Technology |